Navigation Links
Mytrus Electronic Informed Consent System Selected for 2013 Product Leadership Award in Clinical Trials
Date:8/26/2013

SAN FRANCISCO, CA (PRWEB) August 26, 2013

Mytrus Inc. announced today that they have been awarded Frost & Sullivan’s prestigious clinical trials product leadership award for their pioneering electronic informed consent application, enroll™.

Frost & Sullivan, a respected global research organization that tracks more than 250,000 companies, compared Mytrus to other market competitors in a rigorous review that touched on several elements of product design, adoption, ease of use and market potential. At the end of the review, Mytrus was named winner of the North American Product Leadership Award in Clinical Trials for 2013.

“Mytrus has developed a product that makes the cumbersome, but critical process of informed consent simple and efficient for patients and offers sponsors and regulators new opportunities to collect and track important informed consent data analytics,” said Prakhar Verma, Industry Analyst at Frost & Sullivan. “Like other truly disruptive innovations, enroll™ is simple yet powerful and defines a new market for collecting clinical trial consent electronically on all research studies.”

Informed consent forms typically run 8 to 50 pages of often-complex legal and medical information. Participants frequently fail to read or understand the documents before they consent to participating in a trial. Further, there are no requirements for assessing participants’ understanding of the protocol or risks.

“Informed consent is one of the most important, but often neglected, elements of enrolling patients in clinical trials” said Mytrus CEO Anthony Costello. “We are humbled to receive this award for our work in the area of eConsent and we are encouraged to see the number of companies rushing to adopt more patient-centered tools for clinical research.”

According to ClinicalTrials.gov, there were more than 60,000 registered clinical trials ongoing in the United States last June and the number is growing. Studies are often long and complex. The time and effort spent recruiting patients can represent a third of the cost of trials, yet once enrolled in a trial, patients often drop out due to poor understanding of the treatment protocol. All of this contributes, in the end, to higher drug development costs.

A study published earlier this year in the Public Library of Science also showed that patients and investigators receiving information electronically via Mytrus on iPads had far greater comprehension and retention of the material than those receiving the same information on paper.

Earlier this year, inVentiv Health took an equity position in Mytrus, Inc., a pioneer in “virtual clinical trials” and electronic informed consent, as part of a suite of services and technologies inVentiv has assembled to dramatically improve trial efficiency. Mytrus has also partnered with the WIRB-Copernicus Group, the world’s largest provider of regulatory and ethical review services for human research, to deliver enroll™ to customers using the WIRB-Copernicus Group for study ethics review and approval.

Mytrus will accept its award at a gala dinner sponsored by Frost & Sullivan in San Jose, CA on September 11th.

About Mytrus
Founded in 2009, Mytrus is a California-based clinical technology and services company built on the idea that modern technologies can enable people to safely and effectively participate in clinical trials without requiring them to live near a study center. The company’s proprietary methods can dramatically improve patient recruitment timelines, increase patient retention and reduce overall study costs for sponsors. Learn more about Mytrus at http://www.mytrus.com or find the company on Facebook and Twitter @mytrus.

Read the full story at http://www.prweb.com/releases/informed-consent/mytrus/prweb11057997.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Researching graphene nanoelectronics for a post-silicon world
2. UCSB professor receives award for graphene electronics research
3. Researchers develop one of the worlds smallest electronic circuits
4. New path to flex and stretch electronics
5. Nanowiggles: Scientists discover graphene nanomaterials with tunable functionality in electronics
6. Smaller and more powerful electronics requires the understanding of quantum jamming physics
7. Keeping electronics cool
8. Graphene electronics moves into a third dimension
9. Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System
10. A step toward better electronics
11. Functional oxide thin films create new field of oxide electronics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... April 27, 2016 , ... Cambridge Semantics, the leading provider ... announced that it has been named to The Silicon Review’s “20 Fastest Growing Big ... markets, Cambridge Semantics serves the needs of end users facing some of the most ...
(Date:4/27/2016)... April 27, 2016 NanoStruck ... (OTCPink: NSKQB) ( Frankfurt : 8NSK) ... Pressemitteilung vom 13. August 2015 die Genehmigung von ... um zusätzliche 200.000.000 Einheiten auf 400.000.000 Einheiten zu ... bringen. Davon wurden 157.900.000 Einheiten mit dem ersten ...
(Date:4/27/2016)... ... April 27, 2016 , ... PathSensors, Inc., a leading environmental ... Lamka will assist PathSensors in expanding the use of the company’s CANARY® technology ... test platform for the detection of harmful pathogens, including a number of bacteria, ...
(Date:4/27/2016)... MedDay, a biotechnology company focused on the treatment ... Moukheibir as Chairman of its Board of Directors. ... , who contributed to the rapid development of the Company ... started her career in strategy consulting and investment banking in ... .  She held C-Suite level roles in some of ...
Breaking Biology Technology:
(Date:3/11/2016)... PUNE, India , March 11, 2016 ... to a new market research report "Image Recognition Market ... by Application (Marketing and Advertising), by Deployment Type (On-Premises ... Global Forecast To 2022", published by MarketsandMarkets, the global ... in 2015 to USD 29.98 Billion by 2020, at ...
(Date:3/9/2016)... YORK , March 9, 2016 This ... and future states of the RNA Sequencing (RNA Seq) ... segments such as instruments, tools and reagents, data analysis, ... Analyze various segments of the RNA-Sequencing market such as ... services Identify the main factors affecting each segment and ...
(Date:3/8/2016)... 2016   Valencell , the leading innovator ... has secured $11M in Series D financing. The ... venture fund being launched by UAE-based financial services ... investors TDF Ventures and WSJ Joshua Fund. Valencell ... triple-digit growth and accelerate its pioneering innovation in ...
Breaking Biology News(10 mins):